Todd Villines: Developing Reversal Agents for Newer Anticoagulants

Video

The development of new novel oral anticoagulants has made a definite impact in the field in a short period of time. Work is being done to bring reversal agents into the field which can work with these new medications.

The development of new novel oral anticoagulants has made a definite impact in the field in a short period of time. Work is being done to bring reversal agents into the field which can work with these new medications.

With the newer anticoagulants having been approved up to 6 years ago there is currently only one reversal agent available for one of the medications according to Lt. Col. Todd C. Villines, MD, from Walter Reed National Military Medical Center. Villines discussed the developments in the field during the annual meeting of the American College of Cardiology. As a military doctor Villines said service members who are on anticoagulants have different rules and different roles as a result but can still serve while being aware of their medical needs.

Related Videos
HCPLive Five at ACC 2024 | Image Credit: HCPLive
Ankeet Bhatt, MD, MBA | Credit: X.com
Ankeet Bhatt, MD, MBA | Credit: X.com
Sara Saberi, MD | Credit: University of Michigan
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Albert Foa, MD, PhD | Credit: HCPLive
Veraprapas Kittipibul, MD | Credit: X.com
Heart Failure stock imagery. | Credit: Fotolia
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
© 2024 MJH Life Sciences

All rights reserved.